29.10.2021 /
- 07.02.2025 / U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer Therapy
- 15.01.2025 / Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture
- 15.01.2025 / FDA Clears Ariceum Therapeutics’ 225Ac-Satoreotide Phase I/II Clinical Study in Patients with Small Cell Lung Cancer or Merkel Cell Carcinoma
